Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Active OTC stocks -- Ignore unavailable to you. Want to Upgrade?

To: Postman who wrote (764)	7/15/1998 10:18:00 AM
From: JustMy2Cents	Respond to of 1058

ADOT PR on Biomoda Lung Cancer Cure is out on Business Wire Biomoda Conducting Blind-Study of Early Detection Lung Cancer Test Through LungCheck of Scottsdale, Arizona Patented Technology Presents A Leading Hope for Lung Cancer Cure ALBUQUERQUE, N.M.--(BUSINESS WIRE)--July 15, 1998--Advanced Optics Electronics, Inc. (OTC BB: ADOT) today announced significant developments regarding Biomoda, Inc., a biotechnology company in which Advanced Optics has approximately 27% ownership. Biomoda, Inc. has contracted with LungCheck(R), Inc. of Scottsdale, AZ to perform a 60-patient blind-study on Biomoda's proprietary lung cancer diagnosis technology. LungCheck is a respected cytopathology lab chosen for their familiarity with sputum technology. Biomoda's patented lung cancer test is capable of detecting lung cancer up to six years earlier than any other available test. LungCheck's blind-study of Biomoda's revolutionary technology should be completed by September. The results of this blind-study will be presented to recognized medical journals and will provide the third-party verification necessary for presentation to the national media. Biomoda's technology also encompasses the treatment of lung cancer. Biomoda's prominent research team has included world-leading cytopathologists, Dr. Geno Saccomanno of St. Mary's Hospital and Medical Center, Dr. Jim Mulshine of the National Cancer Institute and the late Dr. John Frost of Johns Hopkins University. Biomoda believes this technology is a leading hope for a cure for lung cancer. FDA approval will not be necessary for the patented non-invasive lung cancer test, but will be required for the patented treatment process. Biomoda, Inc. is currently in discussions with several major pharmaceutical companies regarding this patented technology. It is anticipated that results from this latest round of studies will provide Biomoda with the data necessary to conclude major marketing and distribution agreements with several major partners in the United States and abroad. This press release contains forward-looking statements with respect to the results of operations, expectations and business of the Company that involves risk and uncertainties. The Company's actual future results could materially differ from those discussed. Risks and uncertainties of the Company will be detailed from time to time in the Company's periodic reports to be filed with the Securities and Exchange Commission. ADVANCED OPTICS COMPANY INFORMATION Advanced Optics Electronics, Inc. (OTC Bulletin Board: ADOT - news) is a developer of patented electronic display technology, utilizing ADOT's proprietary SLM (Spatial Light Modulator) light valve. This industry-leading technology can be utilized in many diverse fields including the production of "television quality" advertising billboards, medical testing equipment, military displays, computer monitors and high definition video transmission. Advanced Optics Electronics actively seeks partnerships with companies in fields that could benefit from ADOT's patented technology. ADOT also owns in excess of 27% of Biomoda, Inc., an emerging biotechnology company specializing in breakthrough cancer diagnostics and therapy. Advanced Optics Electronics, Inc. has retained first right of refusal to design, manufacture and distribute the necessary scanning testing devices for the lung cancer tests using Advanced Optics Electronics' proprietary display technology. Contact Advanced Optics Electronics, Inc. at (505) 797-7878 or visit their web site at adot.org.

To: Postman who wrote (764)	7/15/1998 10:19:00 AM
From: JustMy2Cents	Read Replies (1) \| Respond to of 1058

Wednesday July 15, 9:30 am Eastern Time Company Press Release SOURCE: BAT International SuperBAT Revenues of $100,000 Booked in First Few Weeks Multi-Pronged Approach Includes Internet, Ads, Direct Marketing, Industrial Sales & Retail Chains BURBANK, Calif., July 15 /PRNewswire/ -- BAT International's (OTC Bulletin Board: BAAT - news) new subsidiary, SuperBAT Inc., has sold over $100,000 in anti-friction metal treatment products in the first several weeks of market introduction of its new product line. Sales resulted from only a few preliminary news announcements and distribution agreements. This sales volume was surprising since SuperBAT has not initiated any of its major Internet and TV marketing campaigns. The SuperBAT web site is scheduled for completion in the coming week. This will be coupled with direct response TV ads, which will occur within the next several months. These two approaches will form the backbone of SuperBAT's initial marketing campaign. BAT and its subsidiaries recently exchanged stock to obtain a commitment for $10 million in advertising time to introduce the product line to the U.S. market (see press release 6/19/98). SuperBAT is also using the advertising campaign to sign distribution agreements with major retailers. Retail chains get very excited about stocking a product on their shelves if there is strong product awareness and a means to ''co-advertise'' the product and store. SuperBAT is in discussions with various companies concerning product introduction. Initial advertising and retail introduction will concentrate on a set of ''test markets'' to evaluate ad effectiveness and consider strategies for co-op marketing promotion with retailers. A series of TV, radio and print advertising will feature both SuperBAT and a participating retailer. Special promotional events involving sponsored racecars, drawings and other activities will be used to attract both media and consumer interest in SuperBAT and the retail chain. Information from this initial evaluation will be used to refine a strategy for a national campaign involving both direct response TV ads and major retail chain distribution. Industrial and specialty sales using sales reps and distributor agreements will further supplement marketing efforts. Various sales professionals with extensive contacts in trucking, mining, automotive, manufacturing, drilling and other industries are being hired to establish a strong market base in industrial and transportation sectors. Various manufacturers have also contacted SuperBAT concerning use of the product in marine, auto, printing and other applications. SuperBAT will also be marketing the product internationally through sales agents and distribution agreements. Distribution agreements are under negotiation with companies in India, China, Canada and Mexico. BAT International is organized as a holding company with major ownership position in a set of subsidiary companies now commercializing advanced automotive and energy technology products developed by BAT over the last six years, including SuperBAT's anti-friction metal treatment. Other products include electric vehicles, super-efficient or high power engines, advanced batteries and power electronics, electric bicycles and scooters, and electric power generation, (for more information, see BAT's web site at (http://www.baat.com). This press release contains forward-looking statements that should not be used to make an investment decision. Please refer to our web site and other sources for more detailed Company information. SOURCE: BAT International